Predictive index for the onset of medication overuse headache in migraine patients

T Onaya1, M Ishii, H Katoh

  • 1Department of Pathophysiology, Showa University School of Pharmacy, Tokyo 142-8555, Japan.

Insights

Migraine patients may develop medication overuse headache (MOH) due to specific migraine types, diet, and genetic factors like MTHFR and DRD2 gene polymorphisms. A predictive index score can identify individuals at higher risk for MOH onset.

Area of Science:

  • Neurology
  • Genetics
  • Epidemiology

Background:

  • Medication overuse headache (MOH) is a common complication in migraine patients.
  • Identifying risk factors for migraine transformation to MOH is crucial for prevention.
  • Current understanding of these risk factors remains incomplete.

Purpose of the Study:

  • To investigate gene polymorphisms, personality traits, headache characteristics, and lifestyle factors associated with migraine progression to MOH.
  • To develop a predictive index (PI) scoring system for MOH onset in migraine patients.

Main Methods:

  • A case-control study involving 47 migraine patients and 22 patients who transitioned from migraine to MOH.
  • Multivariate logistic stepwise regression analysis to identify independent risk factors.
  • Development and validation of a predictive index (PI) score.

Main Results:

  • Migraine type, regular dietary intake, methylenetetrahydrofolate reductase (MTHFR) C677T, and dopamine D2 receptor (DRD2) C939T polymorphisms were significant independent predictors of MOH development (P < 0.05).
  • The developed PI score was significantly higher in MOH patients (7.32 ± 1.60) compared to migraine patients (4.62 ± 1.83, P < 0.001).

Conclusions:

  • Specific migraine types, dietary habits, and genetic variations (MTHFR, DRD2) are key factors in the migraine to MOH transformation.
  • The proposed predictive index offers a potential tool for identifying individuals at risk of developing MOH.
  • Larger studies are needed to validate the predictive index's clinical utility.